BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1392 related articles for article (PubMed ID: 24913723)

  • 1. Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Ritchie C; Smailagic N; Noel-Storr AH; Takwoingi Y; Flicker L; Mason SE; McShane R
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD008782. PubMed ID: 24913723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Ritchie C; Smailagic N; Noel-Storr AH; Ukoumunne O; Ladds EC; Martin S
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010803. PubMed ID: 28328043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (11)C-PIB-PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Zhang S; Smailagic N; Hyde C; Noel-Storr AH; Takwoingi Y; McShane R; Feng J
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD010386. PubMed ID: 25052054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Martínez G; Vernooij RW; Fuentes Padilla P; Zamora J; Bonfill Cosp X; Flicker L
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012216. PubMed ID: 29164603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Martínez G; Vernooij RW; Fuentes Padilla P; Zamora J; Flicker L; Bonfill Cosp X
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012884. PubMed ID: 29164602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F PET with florbetaben for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Martínez G; Vernooij RW; Fuentes Padilla P; Zamora J; Flicker L; Bonfill Cosp X
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012883. PubMed ID: 29164600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).
    Arevalo-Rodriguez I; Smailagic N; Roqué I Figuls M; Ciapponi A; Sanchez-Perez E; Giannakou A; Pedraza OL; Bonfill Cosp X; Cullum S
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010783. PubMed ID: 25740785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI).
    Arevalo-Rodriguez I; Smailagic N; Roqué-Figuls M; Ciapponi A; Sanchez-Perez E; Giannakou A; Pedraza OL; Bonfill Cosp X; Cullum S
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD010783. PubMed ID: 34313331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Smailagic N; Vacante M; Hyde C; Martin S; Ukoumunne O; Sachpekidis C
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010632. PubMed ID: 25629415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma and cerebrospinal fluid ABeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care setting.
    Kokkinou M; Beishon LC; Smailagic N; Noel-Storr AH; Hyde C; Ukoumunne O; Worrall RE; Hayen A; Desai M; Ashok AH; Paul EJ; Georgopoulou A; Casoli T; Quinn TJ; Ritchie CW
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD010945. PubMed ID: 33566374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a secondary care setting.
    Chan CC; Fage BA; Burton JK; Smailagic N; Gill SS; Herrmann N; Nikolaou V; Quinn TJ; Noel-Storr AH; Seitz DP
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011414. PubMed ID: 31521064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the detection of dementia within community dwelling populations.
    Quinn TJ; Fearon P; Noel-Storr AH; Young C; McShane R; Stott DJ
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD010079. PubMed ID: 34278562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mini-Cog for the detection of dementia within a secondary care setting.
    Chan CC; Fage BA; Burton JK; Smailagic N; Gill SS; Herrmann N; Nikolaou V; Quinn TJ; Noel-Storr AH; Seitz DP
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD011414. PubMed ID: 34260060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional cerebral blood flow single photon emission computed tomography for detection of Frontotemporal dementia in people with suspected dementia.
    Archer HA; Smailagic N; John C; Holmes RB; Takwoingi Y; Coulthard EJ; Cullum S
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD010896. PubMed ID: 26102272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies.
    McCleery J; Morgan S; Bradley KM; Noel-Storr AH; Ansorge O; Hyde C
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010633. PubMed ID: 25632881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within community dwelling populations.
    Quinn TJ; Fearon P; Noel-Storr AH; Young C; McShane R; Stott DJ
    Cochrane Database Syst Rev; 2014 Apr; (4):CD010079. PubMed ID: 24719028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addenbrooke's Cognitive Examination III (ACE-III) and mini-ACE for the detection of dementia and mild cognitive impairment.
    Beishon LC; Batterham AP; Quinn TJ; Nelson CP; Panerai RB; Robinson T; Haunton VJ
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD013282. PubMed ID: 31846066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical judgement by primary care physicians for the diagnosis of all-cause dementia or cognitive impairment in symptomatic people.
    Creavin ST; Noel-Storr AH; Langdon RJ; Richard E; Creavin AL; Cullum S; Purdy S; Ben-Shlomo Y
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD012558. PubMed ID: 35709018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.